SQLE and colorectal cancer: SQLE is a particularly exciting candidate target for the treatment of colorectal cancer because a well-established SQLE inhibitor, Terbinafine, is FDA-approved for anti-fungal treatment 8 and has been shown to efficiently block SQLE activity and cell growth in multiple models of colorectal cancer, including organoids and xenograft mice 4-7.